ArticleDiseases (Basel, Switzerland)2023

Tixagevimab/Cilgavimab as Pre-Exposure Prophylaxis against COVID-19 for Multiple Myeloma Patients: A Prospective Study in the Omicron Era.

Ioannis Ntanasis-Stathopoulos et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.